The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
Abstract
In this study, we show that Δ-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, suppresses host immune reactivity against lung cancer. In two different weakly immunogenic murine lung cancer models, intermittent administration of THC (5 mg/kg, four times/wk i.p. for 4 wk) led to accelerated growth of tumor implants compared with treatment with diluent alone. In contrast to our findings in immunocompetent mice, THC did not affect tumor growth in tumor-bearing SCID mice. The immune inhibitory cytokines, IL-10 and TGF-β, were augmented, while IFN-γ was down-regulated at both the tumor site and in the spleens of THC-treated mice. Administration of either anti-IL-10- or anti-TGF-β-neutralizing Abs prevented the THC-induced enhancement in tumor growth. Both APC and T cells from THC-treated mice showed limited capacities to generate alloreactivity. Furthermore, lymphocytes from THC-treated mice transferred the effect to normal mice, resulting in accelerated tumor growth similar to that seen in the THC-treated mice. THC decreased tumor immunogenicity, as indicated by the limited capacity for tumor-immunized, THC-treated mice to withstand tumor rechallenge. In vivo administration of a specific antagonist of the CB2 cannabinoid receptor also blocked the effects of THC. Our findings suggest the THC promotes tumor growth by inhibiting antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“Understanding of the potential pathways for cannabinoid-mediated immune modulation has been enhanced by discovery of receptors with high affinity for cannabinoids (12, 76).”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets
O'Garra, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80533-6 · Cited by 1,533
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
The role of IL-10 in crossregulation of TH1 and TH2 responses
Mosmann, T. R., & Moore, K. W. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80015-5 · Cited by 768
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Galve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Pulmonary Hazards of Smoking Marijuana as Compared with Tobacco
WU, T.-C., Tashkin, D. P., Djahed, B., & Rose, J. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802113180603 · Cited by 521
Self-citationHuang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Self-citationStolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Self-citationTorre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid, I., & Fontana, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3222 · Cited by 386
BOGDAN, C., & NATHAN, C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35934.x · Cited by 384
Structure-activity relationships in cannabinoids.
Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 370
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 358
Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
Zhang, Z., Morgenstern, H., Spitz, M. R., Tashkin, D. P., Yu, G. P., Marshall, J. R., Hsu, T., & Schantz, S. P. (1999) · PubMed · Cited by 337
Self-citationKim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff, B. J., & Uyemura, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2240 · Cited by 323
Self-citationSpeiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Maeda, H., & Shiraishi, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.73 · Cited by 272
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Self-citationHuman non-small cell lung cancer cells express a type 2 cytokine pattern
(1996) · Lung Cancer · doi:10.1016/0169-5002(96)85851-x · Cited by 257
Alleva, D. G., Burger, C. J., & Elgert, K. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1674 · Cited by 241
A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio, T. J., & Niederkorn, J. Y. (1998) · PubMed · Cited by 240
Cannabinoid receptors and immunity
Klein, T. W., Newton, C., & Friedman, H. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 234
Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production
BALDWIN, G. C., TASHKIN, D. P., BUCKLEY, D. M., PARK, A. N., DUBINETT, S. M., & ROTH, M. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9704146 · Cited by 230
Self-citationTGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · PubMed · Cited by 220
A Novel Role for TGF-β and IL-10 in the Induction of Immune Privilege
D’Orazio, T. J., & Niederkorn, J. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2089 · Cited by 195
Qin, Z., Noffz, G., Mohaupt, M., & Blankenstein, T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.770 · Cited by 193
Marijuana, immunity and infection
Klein, T. W., Friedman, H., & Specter, S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00226-9 · Cited by 192
Huang, M., Sharma, S. P., Mao, J. T., & Dubinett, S. (1996) · Journal of Immunology · doi:10.4049/jimmunol.157.12.5512 · Cited by 184
Self-citationTGF-β1 Alters APC Preference, Polarizing Islet Antigen Responses toward a Th2 Phenotype
King, C., Davies, J., Mueller, R., Lee, M.-S., Krahl, T., Yeung, B., O'Connor, E., & Sarvetnick, N. (1998) · Immunity · doi:10.1016/s1074-7613(00)80565-8 · Cited by 181
On the Carcinogenicity of Marijuana Smoke
Hoffmann, D., Brunnemann, K. D., Gori, G. B., & Wynder, E. L. (1975) · Recent Advances in Phytochemistry · doi:10.1007/978-1-4684-0823-2_3 · Cited by 164
Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock
Bean, A. G., Freiberg, R. A., Andrade, S., Menon, S., & Zlotnik, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4937-4939.1993 · Cited by 162
TGF-β Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1589 · Cited by 161
Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2668 · Cited by 156
Effects of TGF-β on the immune system: implications for cancer immunotherapy
de Visser, K., & Kast, W. M. (1999) · Leukemia · doi:10.1038/sj.leu.2401477 · Cited by 155
Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease
Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151
Medicinal Applications of Delta-9-Tetrahydrocannabinol and Marijuana
Voth, E. A., & Schwartz, R. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-10-199705150-00008 · Cited by 145
Seo, N., Tokura, Y., Takigawa, M., & Egawa, K. (1999) · PubMed · Cited by 144
Sogn, J. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80641-x · Cited by 140
Newton, C., Klein, T., & Friedman, H. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4015-4020.1994 · Cited by 137
Miller, P. W., Sharma, S. P., Stolina, M., Butterfield, L. H., Luo, J., Lin, Y., Dohadwala, M., Batra, R. K., Wu, L., Economou, J. S., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050016157 · Cited by 134
Self-citationMolecular Aspects of Cannabinoid Receptors
Matsuda, L. A. (1997) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.30 · Cited by 132
Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
Sundstedt, A., Höidén, I., Rosendahl, A., Kalland, T., van Rooijen, N., & Dohlsten, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.180 · Cited by 132
Seo, N., TOKURA, Y., Takigawa, M., & Egawa, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.242 · Cited by 129
Assenmacher, M., Löhning, M., Scheffold, A., Manz, R. A., Schmitz, J., & Radbruch, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1534::aid-immu1534>3.0.co;2-r · Cited by 126
Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice.
Florquin, S., Amraoui, Z., Abramowicz, D., & Goldman, M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2618 · Cited by 124
Fargeas, C. A., Wu, C. Y., Nakajima, T., et al. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220833 · Cited by 124
Bejarano, M.-T., Malefyt, R. D. W., Abrams, J. S., Bigler, M., Bacchetta, R., de Vries, J. E., & Roncarolo, M. G. (1992) · International Immunology · doi:10.1093/intimm/4.12.1389 · Cited by 124
McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 116
Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., & Casellas, P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12171-2 · Cited by 115
Crisi, G. M., Santambrogio, L., Hochwald, G. M., Smith, S. R., Carlino, J. A., & Thorbecke, G. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251108 · Cited by 109
Klein, T. W., Newton, C. A., Widen, R., & Friedman, H. (1985) · Journal of Immunopharmacology · doi:10.3109/08923978509026487 · Cited by 102
Miller, C., Ragheb, J. A., & Schwartz, R. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.53 · Cited by 102
Klein, T., Kawakami, Y., Newton, C. A., & Friedman, H. P. (1991) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399109531496 · Cited by 94
Presence and functional regulation of cannabinoid receptors in immune cells
Parolaro, D. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00286-6 · Cited by 87
Marijuana as a Potential Respiratory Tract Carcinogen
Taylor, F. M. (1988) · Southern Medical Journal · doi:10.1097/00007611-198810000-00003 · Cited by 84
Fischer‐Stenger, K., Pettit, D. A. D., & Cabral, G. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39607-2 · Cited by 82
delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.
McCoy, K. L., Gainey, D., & Cabral, G. A. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09609-0 · Cited by 74 · cited 1×
“These findings are consistent with previous studies documenting THC-induced dysfunction in both cell types (2, 4, 10, 16).”
ResultPardoux, C., Asselin‐Paturel, C., Chehimi, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.136 · Cited by 66
Sharma, S. P., Miller, P. W., Stolina, M., Zhu, L., Huang, M., Paul, R. W., & Dubinett, S. M. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300531 · Cited by 66
Self-citationPossible Role of Marijuana Smoking as a Carcinogen in the Development of Lung Cancer at a Young Age
Sridhar, K. S., Raub, W. A., Weatherby, N. L., Metsch, L. R., Surratt, H. L., Inciardi, J. A., DUNCAN, R. C., Anwyl, R. S., & McCoy, C. B. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472442 · Cited by 64
Federal Foolishness and Marijuana
Kassirer, J. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701303360509 · Cited by 61
Hollister, L. E. (1988) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1988.10524364 · Cited by 55
Kaminski, N. E. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00480-7 · Cited by 55
Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55
Cannabinoid Receptors and the Cytokine Network
Klein, T., Newton, C. A., & Friedman, H. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5347-2_24 · Cited by 43
Massi, P., Sacerdote, P., Ponti, W., Fuzio, D., Manfredi, B., Viganò, D., Rubino, T., Bardotti, M., & Parolaro, D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00177-5 · Cited by 42
Fischer‐Stenger, K., Updegrove, A. W., & Cabral, G. A. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43452 · Cited by 36
Cabral, G. A., & Mishkin, E. M. (1989) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398909531243 · Cited by 34
9-Tetrahydrocannabinol Suppresses Macrophage Extrinsic Antiherpesvirus Activity
Cabral, G. A., & Vasquez, R. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-199-43356 · Cited by 34
Kaminski, N. E. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00284-7 · Cited by 31
Zheng, Z., & Specter, S. C. (1996) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(95)00107-7 · Cited by 28
Arata, S., Klein, T. W., Newton, C. A., & Friedman, H. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90590-8 · Cited by 18
Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates
Nahas, G. G. (1991) · Cited by 10
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Gillison, M. L., D'Souza, G., Westra, W., Sugar, E., Xiao, W., Begum, S., & Viscidi, R. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn025 · Cited by 1,543
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Metadata
- Authors
- Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., & Dubinett, S. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07-01
- Volume
- 165
- Issue
- 1
- Pages
- 373-380
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1670328913
- Cited by
- 252
- References
- 83
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.